CLU and cardiovascular disorder: These studies supported that the cardiac EC receptors mentioned above were crucial for angiogenesis in cardiovascular diseases, thus from the side confirming that their corresponding ligands, such as Clu and Hspg2, might serve as the key mediators for the pro-angiogenic effect of npEXO relying on a ligand–receptor interaction manner.